High expression of CHML predicts poor prognosis of multiple myeloma

Multiple myeloma is a hematological tumor with a malignant proliferation of myeloma cells. Although the survival time after treatment has improved, the recurrence rate of MM is still high. Choroideremia-like (CHML) protein is essential for the prenylation modification of various Rab proteins and it...

詳細記述

保存先:
書誌詳細
出版年:J Cancer
主要な著者: Zhang, Weilong, Cao, Ling, Liu, Xiaoni, He, Xue, Zhang, Ye, Yang, Zuozhen, Yang, Ping, Wang, Jing, Hu, Kai, Zhang, Xiuru, Liu, Weiyou, Yuan, Xiaoliang, Jing, Hongmei
フォーマット: Artigo
言語:Inglês
出版事項: Ivyspring International Publisher 2019
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6856588/
https://ncbi.nlm.nih.gov/pubmed/31762814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.34465
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料